Paul Mampilly Outlines The Successful Stock Market Segments

Wall Street has two types of investors: the lucky ones and the successful ones. Paul Mampilly falls in the successful group. The trader has extensive experience in making investments. Over the years, he has come up with pointers that help him to know which stocks are destined for success and those that are set to fail. This market acumen has seen him create wealth for both his clients and himself.

The question in most people’s minds is ‘How does he do this?’ According to Paul, the answer is simple, good research. When Paul Mampilly is researching on a stock’s viability, the investor spends between 30 and 40 hours doing research on the company and its market segment. This situation enables Mampilly to determine factors like the sector’s potential, the company’s financial history, its market share, and its management quality. After completing the research, he compiles a report that underscores his recommendation. It takes him between 20 and 30 hours to write the report. According to his recent analysis of the market segments, the financial expert recommended three areas to investors: electric vehicles, food delivery services, and precision medicine.

Follow Paul Mampilly on Twitter.

Food delivery services are becoming popular each day. This popularity is enhanced by millennials’ love for comfort. It also helps the generation to focus on their activities instead of wasting time walking or driving to a restaurant. According to Paul, this demand is expected to increase, thus resulting into handsome returns to the investors.

Just like the ‘iPhone Revolution,’ electric cars are creating a revolution in the auto-making industry. With the launch of more advanced vehicles such as the Tesla’s Model 3, consumers are becoming more convinced that electric cars are the right way to go. This situation has resulted in the increase of share prices for the different companies in this industry. Precision medicine industry is also an ideal area to invest in. The industry is expected to perform even better as the technology related to precision medicine improves.

Paul Mampilly is a revered entrepreneur, investor, author, and editor. Previously, he worked in the Wall Street as a hedge fund expert for ING and Deutsche Asset Management. Paul has also worked for the Royal Bank of Scotland, Sears, and Trust.

For more information about Paul Mampilly, just click here.

Leave a Reply

Your email address will not be published. Required fields are marked *